Behçet's syndrome patients exhibit specific microbiome signature

Autoimmunity Reviews

Volumn 14, Issue 4, 2015, Pages 269-276

  Consolandi, Clarissa ^a   Turroni, Silvia ^b   Emmi, Giacomo ^c   Severgnini, Marco ^a   Fiori, Jessica ^b   Peano, Clelia ^a   Biagi, Elena ^b   Grassi, Alessia ^c   Rampelli, Simone ^b   Silvestri, Elena ^c   Centanni, Manuela ^b   Cianchi, Fabio ^e   Gotti, Roberto ^b   Emmi, Lorenzo ^d   Brigidi, Patrizia ^b   Bizzaro, Nicola ^f   De Bellis, Gianluca ^a   Prisco, Domenico ^c,d   Candela, Marco ^b   D'Elios, Mario M ^c,d  

^a INSTITUTE OF BIOMEDICAL TECHNOLOGIES   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d CAREGGI UNIVERSITY HOSPITAL   (Italy)

^e UNIVERSITY OF FLORENCE   (Italy)

^f San Antonio Hospital   (Italy)

Author keywords

Beh et; Gut microbiota; Immune system response; Pyrosequencing

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL RNA; BUTYRIC ACID; PROBIOTIC AGENT; RIBOSOME DNA; RNA 16S; FATTY ACID;

ADULT; ANTIBIOTIC THERAPY; BACTEROIDACEAE; BACTEROIDETES; BEHCET DISEASE; BIFIDOBACTERIACEAE; BIOINFORMATICS; CLINICAL ARTICLE; CLOSTRIDIALES; CONTROLLED STUDY; DIET THERAPY; DYSBIOSIS; ENTEROBACTERIACEAE; ERYSIPELOTRICHACEAE; EUBACTERIACEAE; FATTY ACID SYNTHESIS; FECES MICROFLORA; FEMALE; HUMAN; INTESTINE FLORA; LACHNOSPIRACEAE; LYMPHOCYTE DIFFERENTIATION; MALE; MICROBIAL DIVERSITY; MICROBIOME; NONHUMAN; PORPHYROMONADACEAE; PYROSEQUENCING; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; REVIEW; RIKENELLACEAE; ROSEBURIA; RUMINOCOCCACEAE; SUBDOLIGRANULUM; FECES; MICROBIOLOGY; MICROFLORA; PATHOLOGY;

ADULT; BEHCET SYNDROME; DYSBIOSIS; FATTY ACIDS; FECES; FEMALE; HUMANS; MALE; MICROBIOTA;

EID: 84923061194     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2014.11.009     Document Type: Review

References (53)

1. Mendoza-Pinto C., Garcia-Carrasco M., Jimenez-Hernandez M., Jimenez Hernandez C., Riebeling-Navarro C., Nava Zavala A., et al. Etiopathogenesis of Behcet's disease. Autoimmun Rev 2010, 9:241-245.
2. Emmi L. Behcet's syndrome - from pathogenesis to treatment 2014, Springer, Heidelberg.
3. Jennette J.C., Falk R.J., Bacon P.A., Basu N., Cid M.C., Ferrario F., et al. 2012 Revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Arthritis Rheum 2013, 65:1-11.
4. Sakane T., Takeno M., Suzuki N., Inaba G. Behcet's disease. N Engl J Med 1999, 341:1284-1291.
5. International Study Group for Behçet's Disease Criteria for diagnosis of Behçet's disease. Lancet 1990, 335:1078-1080.
6. International Team for the Revision of the International Criteria for Behçet's Disease (ITR-ICBD), Davatchi F., Assaad-Khalil S., Calamia K.T., Crook J.E., Sadeghi-Abdollahi B., Schirmer M., et al. The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol 2014, 28:338-347.
7. de Menthon M., Lavalley M.P., Maldini C., Guillevin L., Mahr A. HLA-B51/B5 and the risk of Behcet's disease: a systematic review and meta-analysis of case-control genetic association studies. Arthritis Rheum 2009, 61:1287-1296.
8. Yazici H., Akokan G., Yalçin B., Müftüoğlu A. The high prevalence of HLA-B5 in Behçet's disease. Clin Exp Immunol 1977, 30:259-261.
9. Mizuki N., Inoko H., Ohno S. Pathogenic gene responsible for the predisposition of Behcet's disease. Int Rev Immunol 1997, 14:33-48.
10. Soylu M., Ersoz T.R., Erken E. The association between HLA B5 and ocular involvement in Behcet's disease in southern Turkey. Acta Ophthalmol (Copenh) 1992, 70:786-789.
11. Chamorro A.J., Marcos M., Hernandez-Garcia I., Calvo A., Mejia J.C., Cervera R., et al. Association of allelic variants of factor V Leiden, prothrombin and methylenetetrahydrofolate reductase with thrombosis or ocular involvement in Behcet's disease: a systematic review and meta-analysis. Autoimmun Rev 2013, 12:607-616.
12. Yazici H. The lumps and bumps of Behcet's syndrome. Autoimmun Rev 2004, 3(Suppl. 1):S53-S54.
13. Mizushima Y., Matsuda T., Hoshi K., Ohno S. Induction of Behcet's disease symptoms after dental treatment and streptococcal antigen skin test. J Rheumatol 1988, 15:1029-1030.
14. Mumcu G., Inanc N., Aydin S.Z., Ergun T., Direskeneli H. Association of salivary S. mutans colonisation and mannose-binding lectin deficiency with gender in Behcet's disease. Clin Exp Rheumatol 2009, 27:S32-S36.
15. Tojo M., Yanagihori H., Zheng X., Oyama N., Isogai E., Nakamura K., et al. Detection of microbial DNA in skin lesions from patients with Behcet's disease. Adv Exp Med Biol 2003, 528:185-190.
16. Yokota K., Hayashi S., Araki Y., Isogai E., Kotake S., Yoshikawa K., et al. Characterization of Streptococcus sanguis isolated from patients with Behcet's disease. Microbiol Immunol 1995, 39:729-732.
17. Zhou Z.Y., Chen S.L., Shen N., Lu Y. Cytokines and Behcet's disease. Autoimmun Rev 2012, 11:699-704.
18. Pineton de Chambrun M., Wechsler B., Geri G., Cacoub P., Saadoun D. New insights into the pathogenesis of Behcet's disease. Autoimmun Rev 2012, 11:687-698.
19. Candela M., Biagi E., Maccaferri S., Turroni S., Brigidi P. Intestinal microbiota is a plastic factor responding to environmental changes. Trends Microbiol 2012, 20:385-391.
20. Neish A.S. Microbes in gastrointestinal health and disease. Gastroenterology 2009, 136:65-80.
21. Gill S.R., Pop M., Deboy R.T., Eckburg P.B., Turnbaugh P.J., Samuel B.S., et al. Metagenomic analysis of the human distal gut microbiome. Science 2006, 312:1355-1359.
22. Backhed F., Ding H., Wang T., Hooper L.V., Koh G.Y., Nagy A., et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 2004, 101:15718-15723.
23. Koropatkin N.M., Cameron E.A., Martens E.C. How glycan metabolism shapes the human gut microbiota. Nat Rev Microbiol 2012, 10:323-335.
24. De Vadder F., Kovatcheva-Datchary P., Goncalves D., Vinera J., Zitoun C., Duchampt A., et al. Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 2014, 156:84-96.
25. Plottel C.S., Blaser M.J. Microbiome and malignancy. Cell Host Microbe 2011, 10:324-335.
26. Round J.L., Mazmanian S.K. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 2009, 9:313-323.
27. Candela M., Biagi E., Turroni S., Maccaferri S., Figini P., Brigidi P. Dynamic efficiency of the human intestinal microbiota. Crit Rev Microbiol 2013, 1-7.
28. Centanni M., Turroni S., Consolandi C., Rampelli S., Peano C., Severgnini M., et al. The enterocyte-associated intestinal microbiota of breast-fed infants and adults responds differently to a TNF-alpha-mediated pro-inflammatory stimulus. PLoS One 2013, 8:e81762.
29. Atarashi K., Tanoue T., Oshima K., Suda W., Nagano Y., Nishikawa H., et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 2013, 500:232-236.
30. Arpaia N., Campbell C., Fan X., Dikiy S., van der Veeken J., deRoos P., et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 2013, 504:451-455.
31. Ivanov I.I., Atarashi K., Manel N., Brodie E.L., Shima T., Karaoz U., et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009, 139:485-498.
32. Lee Y.K., Menezes J.S., Umesaki Y., Mazmanian S.K. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 2011, 108(Suppl. 1):4615-4622.
33. Ma H.D., Wang Y.H., Chang C., Gershwin M.E., Lian Z.X. The intestinal microbiota and microenvironment in liver. Autoimmun Rev 2014, 14:183-191.
34. Severance E.G., Yolken R.H., Eaton W.W. Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling. Schizophr Res 2014, [pii: S0920-9964(14)00319-3]. 10.1016/j.schres.2014.06.027.
35. Bogdanos D.P., Smyk D.S., Invernizzi P., Rigopoulou E.I., Blank M., Pouria S., et al. Infectome: a platform to trace infectious triggers of autoimmunity. Autoimmun Rev 2013, 12:726-740.
36. Candela M., Rampelli S., Turroni S., Severgnini M., Consolandi C., De Bellis G., et al. Unbalance of intestinal microbiota in atopic children. BMC Microbiol 2012, 12:95.
37. D'Elios M.M., Benagiano M., Amedei A., Emmi G. Infections, autoimmunity, and Behcet's syndrome: what liaison? Behcet's syndrome, Rare diseases of the immune system 2014, Springer-Verlag, Italia.
38. Kosiewicz M., Dryden G., Chhabra A., Alard P. Relationship between gut microbiota and development of T cell associated disease. FEBS Lett 2014, 5793:224-225.
39. Salonen A., Nikkila J., Jalanka-Tuovinen J., Immonen O., Rajilic-Stojanovic M., Kekkonen R.A., et al. Comparative analysis of fecal DNA extraction methods with phylogenetic microarray: effective recovery of bacterial and archaeal DNA using mechanical cell lysis. J Microbiol Methods 2010, 81:127-134.
40. Claesson M.J., O'Sullivan O., Wang Q., Nikkila J., Marchesi J.R., Smidt H., et al. Comparative analysis of pyrosequencing and a phylogenetic microarray for exploring microbial community structures in the human distal intestine. PLoS One 2009, 4:e6669.
41. Schnorr S.L., Candela M., Rampelli S., Centanni M., Consolandi C., Basaglia G., et al. Gut microbiome of the Hadza hunter-gatherers. Nat Commun 2014, 5:3654.
42. Caporaso J.G., Kuczynski J., Stombaugh J., Bittinger K., Bushman F.D., Costello E.K., et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 2010, 7:335-336.
43. DeSantis T.Z., Hugenholtz P., Larsen N., Rojas M., Brodie E.L., Keller K., et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol 2006, 72:5069-5072.
44. Saeed A.I., Sharov V., White J., Li J., Liang W., Bhagabati N., et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 2003, 34:374-378.
45. Flint H.J., Bayer E.A., Rincon M.T., Lamed R., White B.A. Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis. Nat Rev Microbiol 2008, 6:121-131.
46. Tong M., Li X., Wegener Parfrey L., Roth B., Ippoliti A., Wei B., et al. A modular organization of the human intestinal mucosal microbiota and its association with inflammatory bowel disease. PLoS One 2013, 8:e80702.
47. Trompette A., Gollwitzer E.S., Yadava K., Sichelstiel A.K., Sprenger N., Ngom-Bru C., et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med 2014, 20:159-166.
48. Segain J.P., Raingeard de la Bletiere D., Bourreille A., Leray V., Gervois N., Rosales C., et al. Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease. Gut 2000, 47:397-403.
49. den Besten G., van Eunen K., Groen A.K., Venema K., Reijngoud D.J., Bakker B.M. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res 2013, 54:2325-2340.
50. Petersson J., Schreiber O., Hansson G.C., Gendler S.J., Velcich A., Lundberg J.O., et al. Importance and regulation of the colonic mucus barrier in a mouse model of colitis. Am J Physiol Gastrointest Liver Physiol 2011, 300:G327-G333.
51. Moco S., Candela M., Chuang E., Draper C., Cominetti O., Montoliou I., et al. Perspectives for systems biology approaches for IBD personalized care: emphasis on gut microbial metabolic activities. Inflamm Bowel Dis 2014, 20(11):2104-2114. 10.1097/MIB.0000000000000116.
52. Candela M., Turroni S., Biagi E., Carbonero F., Rampelli S., Fiorentini C., et al. Inflammation and colorectal cancer, when microbiota-host mutualism breaks. World J Gastroenterol 2014, 20:908-922.
53. Furusawa Y., Obata Y., Fukuda S., Endo T.A., Nakato G., Takahashi D., et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 2013, 504:446-450.